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1.0 EXECUTIVE SUMMARY 
 
In May 2007, what was then the Space Life Sciences Directorate, issued the 2007 Space 
Life Sciences Strategy for Human Space Exploration.  In January 2012, leadership and 
key directorate personnel were once again brought together to assess the current and 
expected future environment against its 2007 Strategy and the Agency and Johnson 
Space Center goals and strategies.  The result was a refined vision and mission, and 
revised goals, objectives, and strategies.  One of the first changes implemented was to 
rename the directorate from Space Life Sciences to Human Health and Performance to 
better reflect our vision and mission. 
 
The most significant change in the directorate from 2007 to the present is the 
integration of the Human Research Program and Crew Health and Safety activities.  
Subsequently, the Human Health and Performance Directorate underwent a 
reorganization to achieve enhanced integration of research and development with 
operations to better support human spaceflight and International Space Station 
utilization.  These changes also enable a more effective and efficient approach to human 
system risk mitigation.  
 
Since 2007, we have also made significant advances in external collaboration and 
implementation of new business models within the directorate and the Agency, and 
through two newly established virtual centers, the NASA Human Health and 
Performance Center and the Center of Excellence for Collaborative Innovation.  Our 
2012 Strategy builds upon these successes to address the Agency’s increased emphasis 
on societal relevance and being a leader in research and development and innovative 
business and communications practices.   
 
The 2012 Human Health and Performance Vision is to lead the world in human health 
and performance innovations for life in space and on Earth.  Our mission is to enable 
optimization of human health and performance throughout all phases of spaceflight. All 
HHPD functions are ultimately aimed at achieving this mission.  Our activities enable 
mission success, optimizing human health and productivity in space before, during, and 
after the actual spaceflight experience of our crews, and include support for ground-
based functions.   Many of our spaceflight innovations also provide solutions for 
terrestrial challenges, thereby enhancing life on Earth. 
 
Our strategic goals are aimed at leading human exploration and ISS utilization, leading 
human health and performance internationally, excelling in management and 
advancement of innovations in health and human system integration, and expanding 
relevance to life on Earth and creating enduring support and enthusiasm for space 
exploration. 
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2.0 INTRODUCTION 
 
In May 2006, what was then the Space Life Sciences Directorate (SLSD) solicited input 
from its NASA and contractor leadership teams to develop a long-range plan aligned 
with Agency and Johnson Space Center (JSC) strategies and goals.  These efforts resulted 
in the 2007 Space Life Sciences Strategy for Human Space Exploration. 
 
In January 2012, leadership and key directorate personnel were once again brought 
together to assess the current and expected future environment against its 2007 
Strategy and the JSC 2012 Strategic Implementation Plan.  The result was a refined 
vision and mission, along with revised goals, objectives, and strategies.  One of the first 
changes implemented was to rename the directorate from Space Life Sciences to 
Human Health and Performance, and this new name will be used throughout this 
document. 
 
  
3.0 HUMAN HEALTH AND PERFORMANCE DIRECTORATE (HHPD) VISION 
and MISSION STATEMENTS 
 
Vision 
“The HHPD leads the world in human health and performance 
innovations for life in space and on Earth” 
  
Mission 
“HHPD capabilities enable optimization of human health and 
performance throughout all phases of spaceflight” 
 
All HHPD functions are ultimately aimed at achieving this mission.  Our activities enable 
mission success, optimizing human health and productivity in space before, during, and 
after the actual spaceflight experience of our crews, and include support for ground-
based functions.   Many of our spaceflight innovations also provide solutions for 
terrestrial challenges, thereby enhancing life on Earth. 
 
4.0 SITUATION ANALYSIS  
 
A situation analysis was conducted to determine where we are today relative to our 
mission and vision, and to identify the factors most likely to influence our strategy 
development and affect achievement of our goals and objectives.  Our assessment of 
the current situation, our stakeholders, trends in life sciences and spaceflight, and our 
internal and external environments is presented below and in Appendices A, B, C and D.      
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4.1 Current Situation (2012) 
 
The most significant change in the directorate from 2007 to the present is the 
integration of the Human Research Program (HRP) and Crew Health and Safety activities 
into HHPD, with oversight of Level II functions by the Human Exploration and Operations 
Mission Directorate (HEOMD).  This aligns with HEOMD’s desire to achieve greater 
integration of research, development with operations to support human spaceflight, 
and enables a more effective and efficient approach to human system risk mitigation. 
Our 2012 strategies and goals are also well aligned with the JSC 2012 Plan as shown in 
Appendix A. 
 
We have made significant advances in external collaboration and implementation of 
new business models within the directorate and the Agency, and through two newly 
established virtual centers, the NASA Human Health and Performance Center (NHHPC) 
and the Center of Excellence for Collaborative Innovation (CoECI).  The NHHPC was 
envisioned in our 2007 plan, was established two years ahead of the planned schedule, 
and has more than 110 diverse member organizations.  
 
The Agency is placing an increasing emphasis on societal relevance, International Space 
Station (ISS) utilization, and focused research and development activity. Commercial and 
non-ISS partner nation spaceflight capabilities are growing, and NASA is increasingly 
dependent on partners (ISS and commercial) for access to spaceflight.  Our funding 
streams are changing, but have remained relatively stable since 2006, and our current 
stakeholders are shown below.  Appendix B includes details of the situation analysis.   
 
2012 Stakeholders include the HEOMD (Human Spaceflight Capabilities, ISS, Commercial 
Spaceflight Development, Advanced Exploration Systems, Space Life and Physical 
Sciences Research and Applications, and Exploration Systems Development), Office of 
the Chief Health and Medical Officer, Office of the Chief Technologist, and Office of the 
Chief Scientist; Flight Crew Operations, Mission Operations, Engineering, and Safety and 
Mission Assurance Directorates at JSC; JSC Management; other NASA centers; our 
international partners: the European Space Agency (ESA), the Canadian Space Agency 
(CSA),  the Japanese Space Agency (JAXA), and the Russian Federal Space Agency 
(Roscosmos); NHHPC and CoECI members; NASA Advisory Committees (National 
Institutes of Health , National Academies of Science, Institute of Medicine, and National 
Research Council); The U.S. Executive Branch, Congress, and the American public.  
 
4.2 What We Expect to Change in the Next Five to Ten Years 
 
We expect many changes in human spaceflight in the next five to ten years.  Over a ten-
year period, Administration and Agency missions will change.  Our current funding 
streams will likely be further reduced and become more diverse across smaller projects, 
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and we will rely more on traditional and new partnerships to achieve our strategic goals. 
Commercial spaceflight will become a reality, both to support NASA and international 
partner missions and to expand access to space via space tourism.  We will create new 
advances in external collaboration and new business models to more effectively drive 
innovation.  Appendix C specifies the full list of what is expected to change over the next 
five years.  
 
4.3 Trends 
 
The most significant trends in human spaceflight that we see emerging are the growing 
number of participants and capabilities in the human spaceflight arena including 
commercial entities and non- ISS partner nations.  Trends within NASA include a 
reduction in funding from historical revenue streams and an emphasis on affordability, a 
focus on exploration beyond low earth orbit (LEO), and an aging workforce and facilities 
that will influence expertise and capabilities.  Additionally, there are trends in terrestrial 
life sciences that will drive changes in human spaceflight practices and processes such as 
advances in commercial diagnostic and treatment modalities, environmental 
monitoring, and information management.   Further, the underlying technologies to 
solve problems for spaceflight are closely linked to solutions for health and 
environmental issues in remote areas on earth.  This similarity opens up the opportunity 
for co-creation among many seemingly diverse organizations (e.g., NASA and many of its 
NHHPC partners).  Appendix C specifies the full list of trends identified.   
 
4.4 SWOT Analysis (Strengths, Weaknesses, Opportunities, and 
Threats) 
 
To identify the key strategies and objectives to pursue goals and the resources and 
capabilities required to achieve these goals, we conducted a Strengths, Weaknesses, 
Opportunities, and Threats (SWOT) analysis.  According to the HHPD leadership team, 
our greatest strengths are our people and the breadth and depth of their expertise; 
second is our leadership in collaborative innovation.  As compared to 2007, we have 
made progress improving our ability to collaborate, communicate with, and leverage 
resources of external organizations, but need to continue to emphasize improvement of 
internal processes, integration, and communication (although in some cases internal 
processes were identified as both a strength and a weakness).  The SWOT analysis is 
presented in Appendix D.    
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5.0 KEY STRATEGIES  
 
Cross-cutting strategies developed in 2007 were assessed and refined to address the 
current environment—these apply broadly to all strategic goals.  Goal-specific strategies 
and objectives are specified in Section 6.0 below. 
 
• Optimize the integrated human system risk management process and continue to 
use the system to prioritize risks and execute tasks 
• Define, develop, and maintain core capabilities and competencies 
• Expand and strengthen strategic relationships  
• Define, communicate and implement a customer-focused business model within the 
directorate 
• Improve our customer focus 
• Enhance internal and external communication in terms meaningful to our 
stakeholders, customers, and the general public 
 
 
6.0 GOALS AND SPECIFIC OBJECTIVES 
 
Goal 1:  Lead Human Exploration  
 
1A. Utilize the ISS to advance life sciences research, technology development, and 
operations to enable exploration at LEO and beyond.   
2012-2016: 
o By 2014, update HRP knowledge gaps, establish metrics, and identify 
gaps that can be closed by 2020  
o Establish occupational surveillance programs to support astronaut health 
by 2013 
o Baseline the Transition to Operations (TTO) process and establish a 
system to track number and performance of deliverables successfully 
transitioned to operations by 2013 
o Secure human productivity data and define metrics to demonstrate gains 
in crew productivity by 2015 
o Improve crew efficiencies on-orbit by 10%  (time savings of task 
completion) by 2016 
o Participate in ongoing Design Reference Mission (DRM) planning and 
development throughout the life cycle of mission design.   
 
2017-2021: 
o Develop optimized, autonomous health care systems and practices for 
exploration missions by 2017 
o Implement three technology demonstration projects on ISS by 2017 
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o Develop one-year ISS human mission capability by 2017 
o Participate in Mars simulation mission planning for 2017 
o Be established as the global medical provider for missions beyond ISS by 
2017 
o Complete preparation for continued ISS operation beyond 2020 by 2018 
o Transfer 50% of research products to operations for approved DRMs by 
2017 and 75% by 2019 
o Complete baseline data collection for lunar crew and deep space 
exploration by 2020  
 
1B.   Leverage HHPD experience and provide services to facilitate successful 
commercialization of LEO 
2012-2016: 
o Establish three HHPD commercial space operators customer agreements 
by 2014 
 
2017-2021: 
o Develop a joint lessons learned database with private industry and other 
federal agencies by 2019 
 
1C.   Expand and leverage strategic relationships and collaborative efforts to advance 
human health and performance innovations that enable extended human 
exploration 
2012-2016: 
o Identify and select best practices and technologies in collaboration with 
the military and industry to refine our Human System Integration (HSI) 
strategy by 2013  
o Expand our customer portfolio by 20% including Advanced Exploration 
Systems, Office of Chief Technologist, commercial space, and non-
traditional markets by 2015 
 
2017-2021: 
o Develop agreements with emerging partners and their biomedical 
community  
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Goal 2:  Lead Internationally 
 
2A.   Lead and integrate international community human health and performance 
capabilities to advance space exploration through established ISS working groups 
and the NHHPC 
2012-2016: 
o Fully participate in and contribute to ISS Team 5 activities for ISS 
utilization by 2013 
o Support Global Exploration Roadmap activities for the human system by 
2014 
o Engage international and commercial partners to develop a consolidated 
evidence base of human spaceflight data by 2014 
o Involve all ISS International Partners (IPs) in HRP data collection and 
exchange by 2014 
o Engage new IPs by 2014 with a focus on India 
o Expand NHHPC international member relationships to 10% By 2015 
 
2017-2021: 
o Develop a consolidated evidence base of human spaceflight data in 
collaboration with international and commercial partners by 2017 
o Develop agreements with new partners’ biomedical community as new 
partners emerge 
 
 
2B.   Maintain and cultivate cooperation with international space life science 
organizations and stakeholders to enhance the Agency Global Exploration 
Roadmap    
2012-2016: 
o Present a plenary and ten papers at the annual Global Space Exploration 
Congress (GLEX) by 2016 
o Present one plenary and ten papers at the annual International 
Astronautical Congress (IAC) in collaboration with international partners 
and with an emphasis on enhancing the Agency Global Exploration 
Roadmap by 2016 
 
2017-2021: 
o Establish a new symposium series at IAC in collaborative innovation by 2017 
o Continue to participate in the annual GLEX and IAC in collaboration with IPs 
and with an emphasis on enhancing the Agency Global Exploration Roadmap  
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Goal 3: Excel in Leadership, Management, and Innovation 
 
3A.   Develop, maintain and leverage core capabilities and world-class expertise in 
human health and performance and management  
2012-2016: 
o Define core capabilities to compare against human system risks and 
perform gap analysis by 2012.  Train, hire, and collaborate to fill the gaps 
by 2016 
o Establish a system for documenting and tracking expertise by 2013 
o Develop a process to identify and track all new and existing HHPD legal 
vehicles for collaborations by 2013  
o Establish a structured project management approach to be applied to all 
integrated operational, development, and research projects by 2013 
o Develop and implement an expansion and utilization plan for Human 
System Academy by 2013 
 Develop HSI training courses for JSC by 2012 
 Increase number of Human System Academy students completing 
programs by 20% by 2014 
 Launch an online Human System Academy by 2014 
o Establish formal succession planning options (e.g., cross-training 
experiences, part-time opportunities for employees per their expertise) 
by 2014 
o Increase peer reviewed publications and patents annually by 5% 
beginning in 2014 
o Establish availability of web-based Graduate Life Sciences training at the 
University of Houston open to all accredited universities by 2015  
2017-2021: 
o Open Human System Academy to external participation by 2017 
 
3B.   Drive advances in human health and performance  
2012-2016: 
o Develop an HSI strategy by 2012 and implement it by 2016 
 Identify and select best practices/technologies to refine HSI 
strategy by 2013 
 Complete integration of HSI into Systems Engineering Handbook 
by 2013 
 Establish an HSI Splinter Group by 2013 
 Integrate HSI into Employee Resource Group manual by 2013 
o Conduct a workshop by 2013 to identify most critical HHP projects with 
potential to impact relevance to life on Earth 
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o Collect metrics on research and development projects that explicitly 
identify terrestrial benefits (e.g., number of Phase III—Technology 
Infusion—Small Business Innovation Research (SBIR) projects by 2014 
o Aggressively pursue human health and performance innovative technical 
and business approaches that drive affordability, sustainability, and 
accountability; identifying and establishing three approaches by 2014 
o Finalize definitions of all known risks and link all human system 
requirements to risks by 2014 
o Collect and analyze research deliverables (e.g., quality, quantity, stage of 
development, where in the pipeline, used to inform community, extent 
to which it mitigated risk, etc.) as they are generated to inform risk 
management process 
 
2017-2021: 
o Ensure HSI operations concepts are captured for extraterrestrial missions 
by 2018 
o Reduce required resupply by 50% to support human health and 
performance by 2018 
o Reduce ground-based real-time support for on board medical and 
environmental activities by 2018 
 
3C.  Define and implement comprehensive information architecture, data 
management, and website integration plans  
 
2012-2016: 
o Fully define the information architecture by 2013 
o Identify all existing sources of NASA data supporting human health and 
performance by 2013 
o Develop process to address requests from public regarding human health 
and performance data by 2013 (Lifetime Surveillance of Astronaut Health 
team) 
o Benchmark current capabilities and practices for data management and 
distribution (internal and external) by 2014 
o Complete development of integrated HHPD website by 2014 
 
2017-2021: 
o Automate the process for dissemination of data emerging from 
users/customers (technically how and what) by 2017 
o Implement best practices for data management and distribution (internal 
and external) based on benchmark by 2017 
o Data will be readily available electronically for public use by 2018 
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3D.   Lead and promote the use of innovation methodologies (e.g., prizes) to advance 
human health and performance innovations and foster a NASA culture that 
embraces collaborative innovation  
2012-2016: 
o Secure agency funding line to support innovation and use of innovative 
methodologies (including implementation) for FY13 and out years 
o Define methods to quantify innovations and return on investment (value) 
to human health and performance by 2013 
o Define needed processes and develop capability to share data resources 
to support innovations by 2013 
o Conduct five external open innovation challenges annually by 2014 
o Develop a framework for strategic decision-making by 2013; evaluate and 
revise to final product by 2014 
o Develop two processes that facilitate utilization of innovation 
methodologies and tools by 2014 
o Continue to operate NASA@Work with 20 challenges annually, and 
produce an annual report of results and metrics for the NASA workforce 
o Provide staff support to the JSC Innovation Day annually, leading at least 
one committee or interactive exhibit 
o Pursue three HHPD Innovation Charge Account (ICA) innovations annually 
o Develop metrics for use of strategic decision-framework by 2016 
 
2017-2021: 
o Continue to operate NASA@Work with 20 challenges annually 
 Produce an annual report of results and metrics for the NASA 
workforce 
o Implement and expand availability of the strategic decision framework 
across the Agency, and incorporate into project management classes by 
2017 
o Conduct five external open innovation challenges annually 
o Develop return on investment analysis of open innovation strategies by 
2017 
o Provide staff support to the JSC Innovation Day annually, leading at least 
one committee or interactive exhibit 
o Incorporate ICA awards into task orders to continue advancement of 
human health and performance innovations 
 
Goal 4: Expand Relevance to Life on Earth 
 
4A.   Utilize the CoECI to leverage resources and promote the use of collaborative 
innovation and prizes across the U.S. Federal Government 
  
Human Health and Performance Strategy    Page 13 of 30 
July 1, 2012   
2012-2016: 
o Develop promotional material (handouts and web based) to create 
awareness of and promote use of innovation methodologies by 2012 
o Create a repository of best practices and applications of collaborative 
innovation methods to be shared with all Federal Agencies by mid-2013  
o Define and implement operational practices to rapidly respond to and 
facilitate the use of open innovation methodologies in other Federal 
Agencies by mid-2013 
o Continue to promote collaboration and co-development of projects that 
cannot be conducted effectively by a single agency per the White House 
Office of Management and Budget (OMB) and White House Office of 
Science and Technology Policy (OSTP) June 2012 memorandum  
 
2017-2021: 
o CoECI is self-sustaining through reimbursable Space Act Agreements by 
2017 
o Establish public access forum for “Collaborating with the Government” 
through the CoECI to demonstrate project collaborations between 
government entities and the public sector by 2017  
 
4B.   Utilize the NHHPC to leverage resources and expand collaborative innovation 
projects, co-development efforts, and communication of benefits to Earth 
2012-2016: 
o Support 2012-2013 development and execution of a human health and 
performance related NASA Grand Challenge (if selected) as encouraged 
by the memorandum on Science and Technology Policy Priorities issued 
by the OMB and OSTP in June 2012 
o The NHHPC engages the CoECI to conduct a prize in support of grand 
challenges by 2015 (a public-private prize)  
o Conduct two NHHPC workshops per year that address applications 
benefiting both space exploration and life on Earth  
o Continue to promote collaboration and co-development of projects that 
cannot be conducted effectively by a single organization  
o Increase international participation in the NHHPC by one organization per 
year in 2012, 2013, and 2014 
o Conduct six Member-to-Member Connect webcasts per year  
 
2017-2021: 
o Continue to promote collaboration and co-development of projects that 
cannot be conducted effectively by a single organization  
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o Conduct two NHHPC workshops per year that address applications 
benefiting both space exploration and life on Earth  
o Develop one international collaborative project by 2017   
o Conduct six Member-to-Member Connect webcasts per year  
o Establish a collaborative agreement with :envihab by 2017 
 
4C.   Enhance communications and events to promote and demonstrate relevance to 
life on Earth and create public support and enthusiasm for human space 
exploration 
2012-2016: 
o Develop a strategic communications and marketing plan to promote and 
demonstrate relevance of HHPD, NHHPC, and CoECI by 2012 
o Collaborate with NASA Headquarters Office of Communications and 
other Agency offices to participate in Agency-level efforts for outreach 
and communication to the public 
o Integrate HHPD external website to promote relevancy of HHPD efforts 
and to attract business from external commercial entities by 2014 
o Continue to use Twitter and other relevant social media formats to 
convey the goals and objectives of the NHHPC, CoECI and the HHPD 
o Establish the “human as a system” presence on the JSC homepage and 
external websites by 2013 
o Conduct four Innovation Lecture Series events for HHPD, NHHPC and 
CoECI participants 
 
2017-2021: 
o Hold NASA HHPD supported Science Fair or other educational activity to 
increase public awareness by 2018 
o Pursue and establish partnership with educational publisher to provide 
content for HHP-related text by 2018 
o Incorporate other virtual publication formats into the HHPD publication 
process (example: eBooks on iTunes) 
o Host the first HHPD tweet-up focused on health aspects of human 
spaceflight 
o Create YouTube HHPD library that promotes facilities, core capabilities 
and technical accomplishment of the directorate  
 
4D.   Use HHPD world-class expertise to promote Science, Engineering, Technology and 
Math (STEM) education and create opportunities to inspire the next generation of 
life scientists  
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2012-2016: 
o Develop an external package for workforce to use in Education and 
Outreach (E&O) initiatives by 2012 
o Assess and coordinate all existing educational activities in human health 
and performance within the Agency, Office of Education, and supported 
institutions by 2013 
o Develop K-12 education contests that highlight NASA-generated HHP 
innovations by 2013 
o Infuse NASA Education with STELLAR made available to their educators 
and via nasa.gov by 2013 
o Develop a concerted effort with JSC E&O to leverage NASA Headquarters 
E&O funding/support and identify education funding opportunities by 
2014 
o Document and track current E&O efforts currently conducted by HHPD 
civil servants and contractors by 2014 and build into an overall strategy 
for HHPD E&O by 2014 
 
2017-2021: 
o Wherever practical and appropriate, embed E&O in HHPD projects  
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Appendix A:  Human Health and Performance Directorate Line of Sight 
with the JSC Strategy 
  
 
 JSC 2012 HHPD 2012 
Vision • JSC leads a global enterprise in 
human space exploration that 
is sustainable, affordable, and 
benefits all humankind. 
• The HHPD leads the world in 
human health and 
performance innovations for 
life in space and on Earth 
Mission • JSC provides and applies the 
preeminent capabilities to 
develop, operate, and 
integrate human exploration 
missions spanning commercial, 
academic, international, and 
US government partners.  
• HHPD capabilities enable 
optimization of human health 
and performance throughout 
all phases of spaceflight  
Goal 1:  
Lead Human 
Exploration 
• Exploit the ISS as a cornerstone 
of human exploration 
• Enable the commercialization 
of LEO 
• Extend human exploration 
beyond LEO 
• Utilize the ISS to advance life 
sciences research, technology 
development, and operations 
to enable exploration beyond 
LEO 
• Leverage HHPD experience and 
provide services to facilitate 
successful commercialization 
of LEO 
• Expand and leverage strategic 
relationships and collaborative 
efforts to advance human 
health and performance and 
innovations to extend human 
exploration 
Goal 2: 
Lead 
Internationally 
• Leverage ISS experience to lead 
international community 
participation in human space 
exploration 
• Guide development of Agency 
Global Exploration Roadmap  
• Lead and integrate 
international community 
human health and 
performance capabilities to 
advance space exploration 
through established ISS 
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• Champion international 
participation in the 
development of exploration 
capabilities 
 
working groups and the NASA 
Human Health and 
Performance Center (NHHPC)  
• Maintain and cultivate 
cooperation with international 
space life science organizations 
and stakeholders to enhance 
the Agency Global Exploration 
Roadmap    
Goal 3:  
Excel in 
Leadership, 
Management, 
and 
Innovation 
• Lead through innovative 
technical and business 
management practices 
• Lead by fully engaging the 
human spaceflight team  
 
• Develop, maintain and 
leverage core capabilities and 
world-class expertise in human 
health and performance and 
management  
• Drive advances in human 
health and performance  
• Define and implement 
comprehensive information 
architecture, data 
management, and website 
integration plans  
• Lead and promote the use of 
innovation methodologies 
(e.g., prizes) to advance human 
health and performance 
innovations and foster a NASA 
culture that embraces 
collaborative innovation  
Goal 4: 
Expand 
Relevance to 
Life on Earth 
 
• Intertwine JSC in mutually 
beneficial partnerships to 
maximize economic and 
societal impact  
• Inform, educate and engage all 
generations to advance human 
space exploration  
• Strategically communicate 
• Utilize the CoECI to leverage 
resources and promote the use 
of collaborative innovation and 
prizes across the U.S. Federal 
Government  
• Utilize the NHHPC to leverage 
resources and expand 
collaborative innovation 
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JSC’s relevance in terms 
meaningful to our stakeholders  
 
projects, co-development 
efforts, and communication of 
benefits to Earth 
• Enhance communications and 
events to promote and 
demonstrate relevance to life 
on Earth and create public 
support and enthusiasm for 
human space exploration  
• Use HHPD world-class 
expertise to promote Science, 
Engineering, Technology and 
Math (STEM) education and 
create opportunities to inspire 
the next generation of life 
scientists 
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Appendix B:  Situational Analysis—Current Situation 2012 
 
• The Human Research Program and Crew Health and Safety have been integrated 
into HHPD; HRP and CHS report to HHPD with oversight of Level II functions by 
HEOMD  
• Funding 
o Funding from STS and Cx ended, current funding  comes from ISS, MPCV, 
Comm Space, AES, COECI, HRP, CHS, CM&O, and OCT 
o HRP, CHS FY 12 budget has remained relatively flat compared to FY 06  
o Budgetary and decision authority remain the responsibility of the 
program managers 
• There is an increased emphasis on ISS utilization, and biomedical support and 
utilization of ISS has been established through 2020 
• There is an increased emphasis on societal relevance 
• There is an ongoing expectation for focused research and development activity  
and crew member occupational healthcare 
• Affordability requirements are driving systems engineering, program 
management, human rating, and requirements policies for practices 
• We have made significant advances in external collaboration and 
implementation of new business models within the directorate and the Agency, 
and through the NHHPC and COECI. 
• There is a lack of unified understanding of the Agency’s direction and significant 
uncertainty with our customer base, including commercial customers and 
partnerships  
• With the conclusion of the Space Shuttle Program, there is now a perception by 
the general public that a human space program no longer exists 
• Commercial crew development program has been established 
• There is a perceived loss of American leadership in human spaceflight with the 
loss of American space transport and the increased spaceflight capability by non-
partnered nations like China and India 
• Health and Medical Technical Authority for Human Space Flight programs resides 
in HHPD 
• The 2012 HHPD Strategic Plan is aligned with JSC 2012 Plan  
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Appendix C:  Trends and What We Expect to Change in the Next Five to 
Ten Years 
 
1. Trends in human spaceflight practices and processes 
 
• Commercial development is playing an increasingly significant role in spaceflight 
• Funding from historical revenue streams are changing and likely to decrease, and 
there is a focus on ‘affordability’ and optimizing core capabilities to meet 
budgetary constraints 
• There will be fewer flight opportunities, less cargo capabilities (up and down 
mass), and exclusively long duration (6 months+) missions vs. short duration 
missions 
• We are seeing an increased emphasis on ISS utilization and utilization for 
exploration 
• There is a growing agency emphasis on beyond LEO exploration and technology 
development  
• NASA will have more involvement with non-traditional aerospace organizations, 
e.g., our interaction with Chilean miners, NHHPC members, etc. 
• There is a growing shift from contractor to civil servant project/program support 
and a move to matrixed personnel 
• A divide between NASA administrative and Congress relative to risk aversion is 
emerging  
• The public is becoming decreasingly interested in spaceflight with the ending of 
the Space Shuttle program 
• Public and stakeholder perceptions of government (bad) vs. commercial space 
(good) or vice versa are growing 
• International Partners are seeing increased utilization and responsibility of ISS 
• NASA has more international dependencies 
• There is a changing Agency philosophy in how we ensure mission safety 
(oversight vs. insight) and a focus to reduce standards and requirements  
• There is a desire to keep all NASA centers healthy 
• NASA’s facilities are aging    
• NASA’s workforce is aging and centers are downsizing resulting in a loss of core 
expertise 
• FAA will is becoming increasingly involved with NASA due to commercial 
activities 
• The use of incentive prizes is increasing within and outside of the Agency 
• We’re seeing an increased utilization of analogs, data sharing and data mining 
efforts, and proactive risk management 
• Vehicle and mission designs are changing and morphing 
• There will be many small projects with multiple funding sources 
• Increased competition for funding 
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2. Trends in terrestrial life sciences that will drive changes in human spaceflight 
practices and processes 
 
• Interest in STEM fields continues to  decline 
• Greater access to remote medical care, telemedicine, non-invasive techniques 
• Autonomous field science capability and medical care and operations 
• Off the shelf technology advances aligned with spaceflight needs: portability, 
user-friendliness, remote guidance, miniaturization, robotics integration 
• Advances in diagnostic and treatment modalities  
• Biomedical technology breakthroughs: stem cells, genetics, bio-robotics, 
nanotechnology, pharmaceutical advancements 
• Corporate advances that influence NASA, e.g., the race car industry 
• Instant access to information/immediate communication/teaming 
• Genetically based medical care/ability to identify individual susceptibility to risk 
enabling personalized treatment 
• A focus on green/organic/sustainability  
• Increasing amounts of digital data  
• Less emphasis on face-to-face communication and personal interaction 
 
3. What we expect to change in the next 5 to 10 years 
 
• The U.S. and NASA Administration will change 
• Funding from historical revenue streams will decrease, the need for and funding 
from new streams will emerge (e.g., OCT, non-federal sources), and our budget 
will become increasingly more complex   
• Our mission will change (e.g., exploration destination), spaceflight will become 
more autonomous, and we will develop capabilities for in-situ analysis 
• The ISS national lab will become active; NASA, IP, and commercial utilization of 
ISS will grow; there will be an increased IP management of ISS; however there is 
a potential for termination of ISS in this timeframe as well  
• Commercial crew and cargo will become operational, and there will be growth in 
commercial space access   
• Space tourism will be launched and grow, fliers will be from a broader 
population and the number of fliers will increase, and the need and possibility of 
funding for NASA expertise to support it will grow 
• NASA will exchange medical information with commercial orbital and suborbital 
operators and others 
• The spaceflight capabilities of other nations will grow, and they may experience 
significant advances (e.g., a moon landing by the Chinese) 
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• The U.S. and/or its partners may establish new cooperative agreements or 
partnerships with other nations such as China and India. No American Space 
transport Reduction in the number of NASA centers 
•  Our customer base will change and grow, as will our external partnerships, and 
we will have an increased reliance on external expertise to advance our goals 
• We will create new advances in external collaboration and new business models  
• Human system requirements for commercial human spaceflight will be better 
defined from an operational perspective  
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Appendix D:  SWOT Analysis   
  
The SWOT analysis reflects the outcomes of five different HHPD leadership breakout 
sessions grouped into themes and prioritized (from top to bottom) for each SWOT 
category on the basis of frequency of occurrence.  They are not listed in any particular 
order within each theme.    
 
Strengths (internal, present factors) 
 
People: core capabilities/corporate knowledge 
• Breadth and depth of domain knowledge 
• We hold “the” database for effects and performance for humans in space, the 
leading experts and the expertise for spaceflight.   
• Experience in human spaceflight with past successes 
• World leadership roles in the work we do 
• Knowledge base, subject matter experts, experience in spaceflight 
• Same as 2007: (Our greatest strengths lie in our core capabilities: the unique 
space life sciences research, technology development, and operations 
knowledge, skills, and experience that define us as an organization.)  
• Extremely competent and dedicated workforce—civil servant and contractor 
• Have leading ability to find answers and build research to solve the 
problems/questions 
• Dedication of the people 
• Diverse and talented work force 
• Workforce (diverse, devoted, capable, skilled, adaptability, flexibility, world class 
expertise)  
• Employees interested in participating in Education and outreach 
• Education outreach at every level 
 
Leaders in collaboration and innovation  
• Collaboration is moving to be the norm 
• Open to collaboration and innovation 
• Strong external collaborations (NSBRI, academia etc) 
• We integrate the international life sciences community 
• Good connections to the external communities 
 
Resources/resource management (funding and people) 
• Project Management 
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• Pathfinder, forward-looking 
• Excellent facilities for research 
• Flexibility has allowed the organization to evolve and to survive 
• Mature processes 
Risk management 
• Serious approach to risk management 
• Interdisciplinary atmosphere to solve problems  
• Operations and research housed in one directorate—mission and risk focused 
(drives operations and research) 
• Applied research produces deliverables 
HRP specific 
• Well managed and structured HRP 
• HRP utilization of station 
 
Weaknesses (internal, present factors) 
Management/Processes 
• Not sure Life Sciences skill set the right skill set for the mission we have now, 
how do we manage this skill set in the next 5 years.  Don’t have the flexibility to 
hire and fire like private business, how do we utilize what we have and 
prep/train them to get there.  
• Project Management 
• Resource management (funds and people) 
• Bureaucracy 
• Mature workforce (caps, ceilings)—how to manage? 
• Inability to maintain corporate knowledge 
• Inability to replace corporate knowledge (e.g., lack of succession plan) 
• Poor internal education (corporate knowledge management) 
• Poor career development 
• Transitioning of applied research (deliverables) into operations  
• Hardware development 
• Poor metrics for determining value 
• Ourselves   
• Lack of knowledge management 
• Need to utilize and tap into our work force 
• Lack of unified direction for HHPD 
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Integration/Silos of people, data 
• No singular SA culture (not speaking with one voice) – one team to external 
• Lack of respect between research and medical worlds 
• Poor internal information flow 
• Accessibility of data, understanding and use of data, how usable is it really? Silos 
of research and ops data is an issue other organizations don’t do this to this 
extent 
• What are we doing to optimize and apply to our own programs, for example 
data?  
• Fractured nature of the organization too focused on particular areas of expertise.  
Difficult to navigate across the SA divisions, the program and HRP, how can we 
expect others to be able to?  
• No unified approach 
• Still stove-piped 
• Cross-discipline integration 
• Lateral ties between Ops and Research 
• Communication between divisions, across directorate 
• Lack of engagement across the directorate 
 
Lack of recognition of the value of the human system*  
* This is a perception management issue that addresses both an internal weakness and 
an external threat: internal re: our inability to “sell” the value, externally re: others’ 
perception of that value, but was most often identified as an internal weakness by 
participants 
• Tech develop current situation, an issue for SA because not perceived on critical 
path and hard to obtain funds for development. Limitation if develop technology 
without consideration of human system in the critical path 
• Lack of consideration for the human in the loop on the ground floor of all 
concept design.  Competing priorities between budget and trying to show early 
progress.  
• Lack of focus on Human performance characterization 
• Disconnect between programs and HHP and understanding what is needed and 
HHP knowing how to communicate, speak the language and integrate to 
educate.  
• Significant spaceflight development without SA (HMTA) involvement, a disaster 
waiting to happen- i.e. commercial crew development not enough resources to 
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really support compared to engineering tech authority they can deploy which we 
don’t have 
• Don’t have an equivalent “Saturn rocket” display for Human Spaceflight, where is 
our display. How do we get people excited about the human element and not 
just focus on engineering   
Disconnect with agency vision, our own strategy 
• Personnel are feeling disconnected from the policies. Don’t understand why 
space isn’t addressed specifically in the mission.  
• Is the gen Y really connected to what we are inspired by, are they more 
connected to the current mission statement then we are and we just don’t see 
it? 
• No buy-in for strategic plan 
• Lack of unified direction for agency, center   
• Directorate vision is not pervasive throughout the directorate 
• Timeliness to implementation of vision 
 
Disconnect with stakeholders 
• Seems we have too many stakeholders, certain hierarchy of how we need to 
support. Reflective all specializations, maybe we do not have enough of 
consolidated focus to address stakeholders.  
• The list of stakeholders- doesn’t necessarily recognize themselves as 
stakeholders and recognize the need and relevance for HHP.  We in turn are not 
sure why we should “care” about the stakeholder list.  Thus, we may not be 
serving them appropriately, 
• Directorate visibility is lacking with start-up initiatives 
• Public outreach 
• Demonstrate relevance and benefit to earth (JSC worse than other centers 
historically) 
Risk-based approach misses other possible opportunities 
 
 
Opportunities (external, future focused) 
 
Collaboration/New Initiatives 
• How to capitalize on structure with contractors to capitalize on support to 
commercial space, best ways to align to define goals with commercial space 
• Continue building on external collaborative opportunities and capitalize the lead 
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• Become a recognized leader to external vendors  
• Commercial space industry for partnership 
• Potential for spin-offs and spin-ins 
• Optimizing collaboration with terrestrial life science organizations  
• Growth of international space access 
• Establish collaboration with other government agencies 
• Strong IP relationships – leverage  
• Engage industry to increased partnerships – cutting edge technology, sustain 
core capabilities 
• Texas Med Center growth – increased partnerships 
• Commercial partners – increased national recognition (show our relevance) 
• Skills and knowledge is needed by emerging customers (e.g., commercial, 
international) 
• Leverage non-traditional domain knowledge to solve problems (e.g., 
‘crowdsourcing’) 
• Further integration with international partners (research and operations) (e.g., 
Russia) 
• OZ restructuring (former payloads division in the ISS program office; disbanded 
with tasks assigned to other ISS offices, opportunity for us to provide a better 
integrated HHPD set of payloads, etc.)    
Leadership/policy development  
• Lead the integration and place ourselves in a position of leadership.   
• Insert ourselves as leaders 
• Reduce policies that inhibit leveraging success stories publicly for example 
medical stories, but still protect 
• Rewrite of program management, system engineering, and human rating policies 
• Exercise influence in our leadership roles over external programs e.g. HMTA 
• Rebrand ourselves – enablers vs. obstacles/gatekeepers 
Management/Processes needed to leverage opportunities 
• Create more generalists  
• Tap into diverse talent 
• Empower our people 
• Work well as a team.  
• Integration between research and operations 
• Sharing data and better integrate research and operations side of the house 
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• Creation of informative databases (occupational health and human 
performance) 
 
Stakeholders/funding 
• Diverse budget streams 
• Having more than one customer 
• Emphasizing human system with stakeholders 
• Emerging programs and projects – OCT, AES 
• Ability to identify alternative funding sources 
• Integrate the Human System across many programs 
Image/Image Enhancement 
• NASA brand = good  
• External review is evaluated positively (e.g., IOM) 
• Rebrand ourselves – enablers vs. obstacles/gatekeepers 
• Interest of potential partners to take advantage of the NASA brand 
• Better use of the brand 
• Better communicate relevancy to general public 
 
Threats (external, future focused) 
 
Policy/Leadership 
• Lack of unified direction for agency, center   
• Govt policies impede our abilities   
• Medical privacy rules prohibit good outreach via medical success stories 
• Requirements validation on commercial space not leverage and NASA’s role not 
clearly defined-ops concept HHP and certification of space craft 
• Multi-center survival 
• Laws and policies preventing us from acting like a business 
• Rewrite of program management, system engineering, and human rating 
policies 
• Lack of Clear space policies / direction 
• Ending of ISS program 
• Viability of RSA launch capability 
• National direction changes – lack of five year plan that will stick! 
• Space launch system branding issue within the organization  
• Change of policy, mission, etc. 
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• Leadership gap in human spaceflight diminishing, other international 
organizations more willing to sell information then we are reducing the gap 
further 
Competition/Commercial Space 
• Commercial space have in-house capabilities that creates perception that NASA 
is not needed 
• Competition and risk of losing competent and dedication of work force given 
current state of affairs 
• In competition with contractors to support commercial space-what is NASA’s 
role really? 
• How will we cope with new commercial space work if we achieve commercial 
space opportunities successfully? 
• National Labs 
• Threat of losing SME’s to external entities 
• Commercial space industry for competition 
• Growth of international space access 
• How to capitalize on structure with contractors to capitalize on support to 
commercial space, best ways to align to define goals with commercial space.  
• National labs assistance 
• Commercial failures may impact NASA’s image and success 
Resources   
• Core infrastructure aging (labs, facilities) requires funding 
• Funding 
• Dependence on HRP funding 
• Budget uncertainty 
• Losing core capabilities and aging workforce, aging facilities 
• Budget 
Public Image/Relevancy 
• Public opinion and lack of support for space program 
• E&O has no funding 
• Perception of being risk averse 
• Public interest 
• Loss of the NASA brand 
Limitations of current practices/models 
• Are we sure the data is similar or better/ worse or just different? 
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• Cultural response to models (e.g., push-pull problem) 
• Pace of technology advancement obsolescence  
• Reliance on terrestrial research to mitigate our risks 
 
Lack of recognition of the value of the human system *both an external threat and 
internal weakness, see note above under weaknesses 
 
